Biogen Pushes Finalized Filing for Alzheimer's Drug to Third Quarter

·

·

Biogen Pushes Finalized Filing for Alzheimer's Drug to Third Quarter

Biogen last year said it would ask the FDA to review its potential Alzheimer’s disease treatment, aducanamab, sometime in “early” 2020. The submission is being made under a rolling review, in which sections of an application are filed as they are completed …
See Original Article

Endeavor makes another round of cuts as coronavirus squeezes Hollywood

Financial pressures on Endeavor appear to be mounting, as the Beverly Hills entertainment company announced an additional round of cost-cutting and layoffs in the wake of the coronavirus outbreak. The company, which owns the William Morris Endeavor …
See Original Article

Verizon to again give customers 15GB of free data amid pandemic

In response to the COVID-19 pandemic, Verizon on Wednesday said it would add 15GB of free data to consumer plans for use during the month of May. Verizon is giving consumer and small business customers an additional 15GB of data in May. As part of its …
See Original Article

Xilinx ends fiscal year with record revenues

Xilinx on Wednesday reported record annual revenue for fiscal 2020, with solid growth in its data center business. The chipmaker’s non-GAAP net income for Q4 2020 was $193 million, or 78 cents per diluted share. Revenues were $756 million, down 9 …
See Original Article

CSX profit falls as coal, automotive declines weigh on results

LOS ANGELES (Reuters) – U.S. railroad operator CSX Corp on Wednesday withdrew its financial forecasts and said it was evaluating future spending as business shutdowns because of the COVID-19 pandemic weigh on the U.S. economy. The company …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.